KR20100017565A - (r)-2-메틸피롤리딘 및 (s)-2-메틸피롤리딘 및 이의 타르트레이트 염의 제조 방법 - Google Patents

(r)-2-메틸피롤리딘 및 (s)-2-메틸피롤리딘 및 이의 타르트레이트 염의 제조 방법 Download PDF

Info

Publication number
KR20100017565A
KR20100017565A KR1020097025141A KR20097025141A KR20100017565A KR 20100017565 A KR20100017565 A KR 20100017565A KR 1020097025141 A KR1020097025141 A KR 1020097025141A KR 20097025141 A KR20097025141 A KR 20097025141A KR 20100017565 A KR20100017565 A KR 20100017565A
Authority
KR
South Korea
Prior art keywords
methylpyrrolidine
methyl
tartrate
phenyl
pyrrolidin
Prior art date
Application number
KR1020097025141A
Other languages
English (en)
Korean (ko)
Inventor
마이클 크리스티
조세프 제이. 페트라이티스
Original Assignee
세파론, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 세파론, 인코포레이티드 filed Critical 세파론, 인코포레이티드
Publication of KR20100017565A publication Critical patent/KR20100017565A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Pyrrole Compounds (AREA)
KR1020097025141A 2007-05-03 2008-05-02 (r)-2-메틸피롤리딘 및 (s)-2-메틸피롤리딘 및 이의 타르트레이트 염의 제조 방법 KR20100017565A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92735607P 2007-05-03 2007-05-03
US60/927,356 2007-05-03

Publications (1)

Publication Number Publication Date
KR20100017565A true KR20100017565A (ko) 2010-02-16

Family

ID=39688886

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097025141A KR20100017565A (ko) 2007-05-03 2008-05-02 (r)-2-메틸피롤리딘 및 (s)-2-메틸피롤리딘 및 이의 타르트레이트 염의 제조 방법

Country Status (14)

Country Link
EP (1) EP2152669A1 (pt)
JP (1) JP5698887B2 (pt)
KR (1) KR20100017565A (pt)
CN (1) CN101679237A (pt)
AU (1) AU2008248168B2 (pt)
BR (1) BRPI0810330A2 (pt)
CA (1) CA2686033A1 (pt)
EA (1) EA019031B1 (pt)
IL (1) IL201627A (pt)
MX (1) MX2009011787A (pt)
NZ (1) NZ580948A (pt)
UA (1) UA99913C2 (pt)
WO (1) WO2008137087A1 (pt)
ZA (1) ZA200907643B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2397283T3 (es) 2006-07-25 2013-03-06 Cephalon, Inc. Derivados de piridizinona
US8383657B2 (en) 2007-12-21 2013-02-26 Abbott Laboratories Thiazolylidine urea and amide derivatives and methods of use thereof
EP2752406A1 (en) * 2008-01-30 2014-07-09 Cephalon, Inc. Substituted pyridazine derivatives which have histamine H3 antagonist activity
EP3237408B1 (en) * 2014-12-23 2018-10-31 Cephalon, Inc. Methods for preparing fused bicyclic 2, 4-diaminopyrimidine derivatives

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3329974A1 (de) 1983-08-19 1985-02-28 Bayer Ag, 5090 Leverkusen Herstellung von hydrierten nitrilkautschuken
DE3433392A1 (de) 1984-09-12 1986-03-20 Bayer Ag, 5090 Leverkusen Hydrierung nitrilgruppenhaltiger ungesaettigter polymerer
FR2714849B1 (fr) 1994-01-13 1996-04-05 Inst Francais Du Petrole Procédé de préparation d'un catalyseur d'hydrogénation soluble en phase liquide organique.
DE4403479A1 (de) 1994-02-04 1995-08-10 Basf Ag Verfahren zur Herstellung von Hydroxylammoniumsalzen
WO2004024707A2 (en) * 2002-09-16 2004-03-25 Abbott Laboratories Process for preparing amine type substituted benzofurans
US7153889B2 (en) 2002-11-12 2006-12-26 Abbott Laboratories Bicyclic-substituted amines as histamine-3 receptor ligands
CN100543050C (zh) 2004-03-08 2009-09-23 独立行政法人科学技术振兴机构 高分子担载金属簇组合物
US7145005B2 (en) 2004-05-12 2006-12-05 Abbott Laboratories 2-(6-{2-[(2R)-2-Methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation
ES2299074T3 (es) 2004-06-02 2008-05-16 F. Hoffmann-La Roche Ag Derivados de naftaleno utiles como ligandos del receptor 3 de la histamina.
WO2006059778A1 (ja) 2004-12-01 2006-06-08 Banyu Pharmaceutical Co., Ltd. 置換ピリドン誘導体
JP2008524252A (ja) 2004-12-17 2008-07-10 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Cns障害の処置のためのテトラヒドロイソキノリン化合物
JP2008526895A (ja) 2005-01-21 2008-07-24 シェーリング コーポレイション ヒスタミンh3アンタゴニストとして有用なイミダゾールおよびベンゾイミダゾール誘導体
CA2602336A1 (en) 2005-03-31 2006-10-05 Ucb Pharma S.A. Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
GB0514812D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
CA2627234A1 (en) 2005-10-27 2007-05-03 Ucb Pharma, S.A. Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
WO2007094962A2 (en) 2006-02-09 2007-08-23 Athersys, Inc. Pyrazoles for the treatment of obesity and other cns disorders
WO2007099423A1 (en) 2006-03-02 2007-09-07 Pfizer Products Inc. 1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
US20090163482A1 (en) 2006-03-13 2009-06-25 Mchardy Stanton Furst Tetralines antagonists of the h-3 receptor
WO2008005338A1 (en) 2006-06-29 2008-01-10 Arena Pharmaceuticals, Inc. Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
ES2397283T3 (es) * 2006-07-25 2013-03-06 Cephalon, Inc. Derivados de piridizinona

Also Published As

Publication number Publication date
WO2008137087A1 (en) 2008-11-13
JP5698887B2 (ja) 2015-04-08
IL201627A0 (en) 2010-05-31
CN101679237A (zh) 2010-03-24
JP2010526142A (ja) 2010-07-29
AU2008248168A1 (en) 2008-11-13
AU2008248168B2 (en) 2013-03-21
BRPI0810330A2 (pt) 2014-10-14
NZ580948A (en) 2011-04-29
EA019031B1 (ru) 2013-12-30
ZA200907643B (en) 2014-03-26
EA200971019A1 (ru) 2010-04-30
CA2686033A1 (en) 2008-11-13
UA99913C2 (ru) 2012-10-25
IL201627A (en) 2014-06-30
EP2152669A1 (en) 2010-02-17
MX2009011787A (es) 2009-11-13

Similar Documents

Publication Publication Date Title
US20100121055A1 (en) Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof
JP6491393B2 (ja) ヒストン脱アセチル化酵素6阻害剤としての1,3,4−オキサジアゾール誘導体化合物及びこれを含有する薬剤学的組成物
JP4853965B2 (ja) アダマンタン誘導体およびアザビシクロオクタン誘導体およびアザビシクロノナン誘導体、ならびにこれらの調製方法およびdpp−iv阻害剤としてのこれらの使用
CA2861202C (en) Nicotinamide derivatives or salt thereof having syk-inhibitory activity
JP2019065037A (ja) ヒストン脱アセチル化酵素阻害剤
TW422842B (en) New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
CA2637530A1 (en) Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
JP2012519196A (ja) スルホニル化されたテトラヒドロアゾロピラジンおよびその医薬としての使用
KR20100093103A (ko) 고지혈증 또는 동맥경화증과 같은 질환의 치료에 유용한 cετρ 억제제로서의 1,2-이치환된 4-벤질아미노-피롤리딘 유도체
NZ544046A (en) N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
EA009903B1 (ru) Бициклические [3.1.0] производные в качестве ингибиторов переносчиков глицина
AU2010215524A1 (en) Novel ortho-aminoamides for the treatment of cancer
MX2011003533A (es) Compuestos novedosos como bloqueadores del canal de calcio.
KR20090092774A (ko) 치환된 2,5-디히드로-3h-피라졸로[4,3-c]피리다진-3-온 유도체, 그의 제조법 및 칸나비노이드 cb1 수용체 리간드로서의 그의 용도
KR20230158007A (ko) 항바이러스 화합물
KR20100017565A (ko) (r)-2-메틸피롤리딘 및 (s)-2-메틸피롤리딘 및 이의 타르트레이트 염의 제조 방법
JP2011529471A (ja) 迅速解離性ドーパミン2受容体拮抗薬としてのピペラジン−1−イル−トリフルオロメチル−置換−ピリジン
CA2791431A1 (en) Derivatives of aminoindanes, their preparation and their application in therapeutics
JPH11240832A (ja) アミド若しくはアミン誘導体
ZA200700950B (en) Pyrrole derivatives, their preparation and their therapeutic use
AU2005252178B2 (en) Histamine H3 receptor agents, preparation and therapeutic uses
JPWO2006051851A1 (ja) 2,3,4,5−テトラヒドロ−1h−1,5−ベンゾジアゼピン誘導体、及び、医薬組成物
CA2500115A1 (en) Heterocyclic substituted piperazines for the treatment of schizophrenia
ES2396557T3 (es) Derivado de benciloxipropilamina
JP2004300133A (ja) アミン誘導体

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E601 Decision to refuse application